Yujie Zhao Selected Research

B-Cell Leukemia (Leukemia, B Cell)

1/2022

Identification of two downregulated circRNAs in patients with acute B-lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yujie Zhao Research Topics

Disease

47	Neoplasms (Cancer) 01/2024 - 06/2005
12	Neoplasm Metastasis (Metastasis) 03/2024 - 06/2015
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2015
8	Inflammation (Inflammations) 01/2022 - 03/2013
7	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 11/2017
6	Lung Neoplasms (Lung Cancer) 11/2023 - 06/2007
6	Infections 01/2023 - 02/2012
4	Melanoma (Melanoma, Malignant) 03/2024 - 07/2014
4	COVID-19 11/2023 - 11/2020
4	Adenocarcinoma of Lung 09/2023 - 01/2020
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2017
4	Breast Neoplasms (Breast Cancer) 04/2022 - 01/2020
3	Atrial Fibrillation 02/2024 - 01/2014
3	Necrosis 01/2024 - 01/2017
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 06/2021
3	Carcinogenesis 12/2023 - 11/2017
3	Disease Progression 12/2023 - 01/2021
3	Hypoxia (Hypoxemia) 01/2022 - 01/2013
3	Ovarian Neoplasms (Ovarian Cancer) 07/2021 - 01/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2024 - 01/2021
2	Hepatic Encephalopathy 04/2024 - 12/2023
2	Stroke (Strokes) 04/2024 - 01/2020
2	Metabolic Diseases (Metabolic Disease) 04/2024 - 10/2023
2	Myocardial Infarction 04/2024 - 01/2022
2	Heart Failure 04/2024 - 09/2023
2	Vascular Diseases (Vascular Disease) 01/2024 - 11/2023
2	Ischemic Stroke 01/2024 - 01/2020
2	Lymphoma (Lymphomas) 12/2023 - 02/2022
2	Crohn Disease (Crohn's Disease) 11/2023 - 01/2020
2	Insulin Resistance 10/2023 - 01/2022
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2022 - 10/2020
2	Hepatocellular Carcinoma (Hepatoma) 08/2022 - 02/2016
2	Squamous Cell Carcinoma of Head and Neck 02/2022 - 10/2021
2	Colitis 01/2022 - 11/2017
2	Hemorrhage 01/2022 - 06/2020
2	Cardiac Arrhythmias (Arrythmia) 01/2022 - 10/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 03/2021
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2022
2	Tuberculosis (Tuberculoses) 01/2020 - 08/2009
2	Atherosclerosis 01/2018 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 11/2017
2	Carcinoma (Carcinomatosis) 01/2018 - 02/2015
1	Tonsillar Neoplasms 05/2024
1	Sarcopenia 04/2024

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2015
12	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2013
9	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2021
7	Messenger RNA (mRNA)IBA 01/2024 - 06/2007
6	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2022
5	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2021
4	RNA (Ribonucleic Acid)IBA 01/2024 - 04/2020
3	PlatinumIBA 01/2024 - 07/2021
3	Tumor Biomarkers (Tumor Markers)IBA 01/2024 - 01/2020
3	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 02/2022
3	Interleukin-6 (Interleukin 6)IBA 01/2024 - 11/2017
3	Tyrosine Kinase InhibitorsIBA 07/2023 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 09/2022 - 01/2015
3	Immune Checkpoint ProteinsIBA 01/2022 - 10/2021
3	Protein Isoforms (Isoforms)IBA 08/2018 - 01/2015
2	omega-Chloroacetophenone (Mace)IBA 04/2024 - 09/2023
2	pembrolizumabIBA 03/2024 - 09/2022
2	VaccinesIBA 02/2024 - 06/2021
2	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 07/2021
2	CopperIBA 01/2023 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 08/2009
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2016
2	TicagrelorIBA 01/2022 - 06/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 01/2022
2	CytokinesIBA 10/2021 - 01/2019
2	LigandsIBA 10/2021 - 09/2021
2	Peptide Hydrolases (Proteases)FDA Link 08/2021 - 01/2021
2	Anaplastic Lymphoma KinaseIBA 06/2021 - 01/2020
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2021 - 10/2020
2	nafamostatIBA 01/2021 - 10/2020
2	C-Reactive ProteinIBA 01/2021 - 01/2014
2	AlbuminsIBA 01/2021 - 10/2011
2	Superoxide DismutaseIBA 10/2020 - 09/2020
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 01/2015
2	MatrinesIBA 01/2020 - 01/2017
2	LipidsIBA 01/2019 - 01/2018
2	BerberineIBA 11/2017 - 02/2016
2	Small Interfering RNA (siRNA)IBA 09/2016 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2015 - 01/2015
1	SodiumIBA 04/2024
1	SymportersIBA 04/2024

Therapy/Procedure

23	Therapeutics 04/2024 - 05/2015
15	Immunotherapy 01/2024 - 01/2021
7	Drug Therapy (Chemotherapy) 01/2024 - 12/2015
4	Radiotherapy 05/2024 - 01/2015
4	Precision Medicine 01/2024 - 12/2015
3	Radiofrequency Ablation 01/2023 - 01/2014
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 04/2024 - 12/2023
2	Transjugular Intrahepatic Portasystemic Shunt 04/2024 - 12/2023
2	Catheters 01/2023 - 01/2014
2	Phototherapy (Light Therapy) 01/2022 - 01/2022
2	Artificial Respiration (Mechanical Ventilation) 11/2020 - 07/2019
1	Adjuvant Radiotherapy 05/2024
1	Oral Surgery (Maxillofacial Surgery) 05/2024